A Real-world Study on Golidocitinib-based Therapeutic Regimens for the Treatment of Patients With Peripheral T-cell Lymphoma

NCT06963632 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
1000
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Ruijin Hospital